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IMPORTANCE Womenwith a history of hypertensive disorders of pregnancy (HDP) have
higher risk of cardiovascular disease (CVD). It is not known howmuch of the excess CVD risk
in womenwith a history of HDP is associated with conventional cardiovascular risk factors.
OBJECTIVE To quantify the excess risk of CVD in womenwith a history of HDP and estimate
the proportion associated with conventional cardiovascular risk factors.
DESIGN, SETTING, AND PARTICIPANTS Prospective cohort studywith amedian follow-up of 18
years. Population-based cohort of women participating in the Nord-Trøndelag Health Study in
Norway. We linked data for 31 364women from the Nord-Trøndelag Health Study
(1984-2008) to validated hospital records (1987-2015), the Cause of Death Registry
(1984-2015), and theMedical Birth Registry of Norway (1967-2012). A total of 7399women
were excluded based on selected pregnancy characteristics, incomplete data, or because of
emigrating or experiencing the end point before start of follow-up, leaving 23 885 women for
study. Data were analyzed between January 1, 2018, and June 6, 2018.
EXPOSURES Experiencing 1 or more pregnancies complicated by HDP before age 40 years vs
only experiencing normotensive pregnancies.
MAIN OUTCOMES ANDMEASURES We used Cox proportional hazardsmodels to estimate the
hazard ratios (HRs) for the association between HDP and CVD. The proportion of excess risk
associated with conventional cardiovascular risk factors was estimated using an inverse odds
ratio weighting approach.
RESULTS Our study population consisted of 23 885 parous women fromNord-Trøndelag
County, Norway. A total of 21 766women had only normotensive pregnancies, while 2199
women experienced ever having an HDP. From age 40 to 70 years, womenwith history of
HDP had an increased risk of CVD compared with womenwith only normotensive
pregnancies (HR, 1.57; 95% CI, 1.32-1.87) but not at older age (β = 0.98; 95% CI, 0.96-1.00; P
for interaction by age = .01). Blood pressure and bodymass index were associated with up to
77% of the excess risk of CVD in womenwith history of HDP, while glucose and lipid levels
were associated with smaller proportions.
CONCLUSION AND RELEVANCE In this study, the excess risk of CVD in womenwith history of
HDPwas associated with conventional cardiovascular risk factors, indicating that these risk
factors are important targets for cardiovascular prevention in these women.
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W omenwithhistoryofhypertensivedisordersofpreg-nancy (HDP) have approximately a 2-fold increasedrisk of cardiovascular disease (CVD) comparedwith
women with normotensive pregnancies.1-5 Hypertensive dis-
ordersofpregnancyandCVDsharecommonmodifiableriskfac-
tors, suchasadiposity,hypertension,dyslipidemia, andhyper-
glycemia, that may be targets for prevention. In 2018,6 we
observed that women with HDP already had more adiposity,
higherbloodpressureandglucose levels,andmoreadverse lipid
levels before first pregnancy and that their cardiovascular risk
factor levelsremainedhigherthanwomenwithoutHDPthrough
age 50 years and beyond. It is not known howmuch of the ex-
cess CVD risk inwomenwith history ofHDP is associatedwith
these risk factors vs howmuchmay be caused byHDP itself or
other unidentified factors. This knowledge is crucial to inform
preventive action in women with a history of HDP. In a popu-
lation-based cohort with longitudinal information on cardio-
vascular risk factors and validated information on cardiovas-
cularevents,weusedmediationanalysis toexaminehowmuch
of theexcesscardiovascular risk inwomenwithahistoryofHDP
is associatedwith adverse levels of bodymass index (BMI, cal-
culated as weight in kilograms divided by height in meters
squared), blood pressure, and glucose and lipid levels.
Methods
All procedures performed in studies involvinghumanpartici-
pants were in accordance with the ethical standards of the
Regional Committee for Medical and Health Research Ethics
and with the 1964 Helsinki declaration and its later amend-
ments or comparable ethical standards. The Regional Com-
mittee for Medical and Health Research Ethics granted ethi-
cal approval of the study. In the initial Nord-TrøndelagHealth
Study (HUNT1), attendance and participation in question-
naires and clinical examination was considered as informed
consent, and in HUNT2 and HUNT3, participants gave writ-
ten consent.
Study Population
This study included 23885 parouswomen participating in the
HUNT inNorway.Using theunique identificationnumberof all
Norwegian citizens, we linked information fromHUNT (1984-
2008), the Medical Birth Registry of Norway (MBRN, 1967-
2012), theNorwegianCauseofDeathRegistry (1984-2015), and
validated cardiovascular events fromthe local hospitals (1987-
2015).This linkeddata resourcehaspreviouslybeenusedtoex-
amine the added value of pregnancy complications in clinical
CVD risk prediction.7 See the eAppendix and eFigure in the
Supplement for a description of the sample selection and an
overview of the study timeline with associated data sources.
Exposure and Covariates
ExposurewasdefinedashistoryofHDP (everHDP) in the form
of preeclampsia or gestational hypertension at 40 years or
younger. Additionally, we subclassified the exposure as ever
preeclampsia (with or without a history of gestational hyper-
tension) and ever gestational hypertension (but no history of
preeclampsia) at 40 years or younger. Details about the diag-
noses of preeclampsia and gestational hypertension in the
MBRNand their validity arepresented in theeAppendixof the
Supplement.
We retrieved information about age at HUNT examina-
tion, self-reported ever daily smoking, highest obtained edu-
cational level,worktitles, currentuseofantihypertensivemedi-
cation, and familyhistory of coronaryheart disease (in sibling
or parents) from the HUNT survey questionnaires and inter-
views. For 3530 women for whom educational level was not
available,wededucedhighestobtainededucational level from
their work titles based on recommendations from Statistics
Norway.8 TheMBRNprovided informationonmother’s age at
birth and parity.
Cardiovascular Risk Factors
Information about the most recently measured cardiovascu-
lar risk factors prior to the cardiovascular event or censoring
was obtained from clinical measurements and serum
samples collected at HUNT examinations. Details about the
cardiovascular risk factors measurements have been
reported previously6 and are included in the eAppendix of
the Supplement.
Cardiovascular Events
To obtain information about hospital-diagnosed cardiovascu-
lar events, medical records were retrieved for all study par-
ticipants who had at least 1 record with an International
Classification of Diseases, Ninth Revision (ICD-9) and/or Inter-
national Statistical Classification of Diseases and Related
Health Problems, Tenth Revision (ICD-10) code indicating CVD
in the electronic patient administrative systems of the 2 local
hospitals serving Nord-Trøndelag county between September
1, 1987, and April 24, 2015. All medical records were reviewed
by 1 of 2 cardiologists (B.K. and H.D.) who, according to
established criteria, confirmed any valid cardiovascular diag-
noses. Additional details about the diagnoses and validation
are presented in the eAppendix of the Supplement. We also
obtained information on dates and causes of death up until
April 24, 2015, from the Norwegian Cause of Death Registry,
Key Points
Question Womenwith history of hypertensive pregnancy
disorders have a higher risk of cardiovascular disease, but how
much of their excess cardiovascular risk is associated with
conventional cardiovascular risk factors?
Findings In this cohort study, blood pressure and bodymass
index were associated with up to 77% of the excess risk of
cardiovascular disease in womenwith history of hypertensive
pregnancy disorders, while glucose and lipids were associated
with smaller proportions.
Meaning The association of conventional risk factors, in particular
blood pressure and bodymass index, with the development of
cardiovascular in womenwith history of hypertensive pregnancy
disorders indicate that preventive efforts aimed at decreasing the
levels of these risk factors could reduce cardiovascular risk in
womenwith history of hypertensive pregnancy disorders.
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which has recorded all deaths in Norway since 1951.9 Cardio-
vascular disease–related deaths were identified using ICD-9
and ICD-10 codes for the underlying cause of death (eTable 1
in the Supplement).
Statistical Analysis
We used Cox proportional hazards models10 to estimate the
hazard ratios (HRs) for first-time cardiovascular events (fatal
or nonfatal) and, specifically, first-time myocardial infarc-
tion, heart failure, and cerebrovascular events, comparing
womenwith andwithout a history ofHDP.Weused age as the
timescale, andwomenentered thestudyonSeptember 1, 1987,
their firstHUNTexamination,or age40years,whichever came
last. Womenwere followed up until the cardiovascular event
of interest, emigration fromNord-Trøndelag county, death, or
April 24, 2015, whichever came first. Hazard ratios were ad-
justed for age (model 1) and adjusted for age, maternal birth
year, highest educational level, ever daily smoking, parity be-
fore age 40 years, and family history of coronary heart dis-
ease insiblingorparents (model2).Toassess theeffectofdeath
from causes other than CVD as a competing risk, subdistribu-
tion HRs were also estimated using Fine and Gray competing
riskmodel.11 TheCoxproportionalhazardsassumptionwasas-
sessed by including interactions between independent vari-
ables and time. Violations of theCoxproportional hazards as-
sumptionwerehandledbyestimatingHRswithin separate age
intervals in which the assumption was met.
In secondary analyses, we included only women whose
first birth was recorded in the MBRN to avoid potential mis-
classificationofwomenasnormotensivewhohadearlierpreg-
nanciesnotcapturedby theMBRN.Additionally, toavoidmiss-
ing too many early cardiovascular events at younger than 40
yearsandowing to thecomplexassociationbetweenparityand
HDP,weexaminedHDPinfirstpregnancyasanexposure, start-
ingexposure timeatwhichevercamelast: firstbirth, firstHUNT
participation, or September 1, 1987. In these analyses we ad-
ditionally adjusted for mother’s age at first birth. Finally, be-
cause informationonCVDsubtypes in theCauseofDeathReg-
istrymay have lower validity, we repeated the analyses using
validated myocardial infarction, heart failure, and cerebro-
vascular events from the hospital records only.
Analogously to the study by Tanz et al,12 we have used a
mediation approach to estimate theproportion of excess CVD
risk inwomenwithahistoryofHDPthat is associatedwithcon-
ventional cardiovascular risk factors. Mediation analysis en-
ablesadecompositionof theassociationbetweenexposureand
outcome (called total effect) into a natural direct effect from
exposure onoutcomeandanatural indirect effect fromexpo-
sure on outcome through mediators.13,14 In our analysis, the
natural indirect effect is best interpreted as the proportion of
excess cardiovascular risk inwomenwith history of HDP that
isassociatedwithconventional cardiovascular risk factors (me-
diators), while the natural direct effect is best understood as
theproportionofexcesscardiovascular risk inwomenwhohad
HDPthat isnot associatedwith these factors.Weestimated the
part of the association between HDP and CVD that was asso-
ciated with BMI, systolic and diastolic blood pressure, non-
fasting serum glucose levels, and non–high-density lipopro-
tein (HDL) cholesterol levels (indirect effect) and thepart that
was not associated with these factors (direct effect) using an
inverse odds ratio weighting mediation analysis method.15,16
A graphic and more detailed explanation of this mediation
analysis is given in the Figure. Separate analyses were per-
formed for eachmediator and for the combinationof BMI and
bloodpressure. In themediation analysis,we additionally ad-
justed for the age at measurement of themediator. Addition-
ally, separate mediation analyses were conducted for pre-
eclampsia and gestational hypertension as well as for CVD
subtypes (myocardial infarction, heart failure, and cerebro-
vascular events). Mediators may have been measured before
(maximum of 484women [2%]) or after pregnancies compli-
cated by HDP, but because we do not postulate the associa-
tion between HDP and CVD to be causal and because the dif-
ferences in cardiovascular risk factors between women with
and without HDP are largely similar prepregnancy vs post-
pregnancyandthroughout theage range from20years toolder
than 50 years in this study population,6 the timing of media-
tor measurement was less relevant. In 2 separate sensitivity
analyses, we excluded women who had their cardiovascular
risk factors measured before their first pregnancy and re-
stricted themediation analysis towomenwhohadmediators
measuredat older than40years, the timewhereweendedex-
posure follow-up.All analyseswere performedusing Stata IC,
version 14 (StataCorp).17 ThePvaluewas2-sided, and the level
of statistical significance was .05.
Results
Of 23885 women, 2119 (9%) had a history of HDP at younger
than 40 years; 1391 had at least 1 occurrence of preeclampsia;
Figure. Mediation Analysis
Socioeconomic status, smoking, 
family history of coronary heart 
disease, parity before 40 y, and birth
Prepregnancy BMI, blood pressure,
non-HDL cholesterol, and glucose
Postpregnancy BMI, 
blood pressure, non-HDL
cholesterol, and glucose
Hypertensive
disorders of 
pregnancy
Cardiovascular 
disease
Diagram of associations between hypertensive disorders of pregnancy (HDP);
cardiovascular risk factors in the form of bodymass index (BMI), blood
pressure, and glucose and non–high-density lipoprotein (HDL) cholesterol
levels; and cardiovascular disease. The dark blue arrows indicate proportion of
excess cardiovascular risk in womenwith HDP that is associated with BMI,
blood pressure, and glucose and non-HDL cholesterol levels (indirect effect).
The blue arrows indicate proportion of excess cardiovascular risk in womenwith
HDP that is not associated with BMI, blood pressure, and glucose and non-HDL
cholesterol levels (direct effect). The light blue arrows indicate confounding of
the association between HDP and cardiovascular disease and that between
cardiovascular risk factors and cardiovascular disease by socioeconomic status,
smoking, family history of coronary heart disease, parity at younger than 40
years, andmaternal birth year.
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and 728 experienced gestational hypertension only (Table 1).
Women with history of HDP were less likely to report daily
smoking and more likely to have first births captured by the
MBRN thanwomenwithnormotensive pregnancies (eTable 2
in the Supplement). The median ages at measurement of the
cardiovascular risk factors included in the mediation analy-
sis were 50 years for women with only normotensive preg-
nancies and 48 years for women with a history of HDP. Preg-
nancies complicated by HDP were more likely to result in
preterm delivery or offspring born small for gestational age
(eTable 2 in the Supplement). During a median follow-up of
18 years, 1688 women experienced at least 1 cardiovascular
event, and 1565 (92.7%) had a cardiovascular event validated
fromhospital records.Fivehundred fifty-threeof 1688women
with cardiovascular events experienced a myocardial infarc-
tion, 233hadheart failure, and878 experienced a cerebrovas-
cular event.
Association Between HDP and CVD
Because theproportionalhazards assumptionwasviolated, as
indicated by an interaction between the history of HDP and
time (β = 0.98; 95% CI, 0.96-1.00; P = .01), we estimated HRs
within the age intervals (40-70 years and 70-88 years) sepa-
rately. For the purpose of brevity and clarity, only fully ad-
justed HRs based on model 2 are hereafter described in the
text.WomenwithahistoryofHDPhadan increased riskof any
cardiovascular event (HR, 1.57;95%CI, 1.32-1.86)betweenages
40 and 70 years comparedwithwomenwith only normoten-
sive pregnancies (Table 2). The corresponding HRs were 1.66
(95%CI, 1.34-2.06) forwomenexperiencingpreeclampsia and
1.43 (95% CI, 1.09-1.88) for women experiencing gestational
hypertension only. For women older than 70 years, the asso-
ciationwas reversed, andwomenwith a history of HDP had a
lower riskof anycardiovascular event (HR,0.60;95%CI,0.34-
1.04) compared with women with only normotensive preg-
nancies. The results were broadly similar for women with
preeclampsia and gestational hypertension.
Women with a history of HDP had an increased risk of
myocardial infarction (HR, 1.86; 95%CI, 1.40-2.48), heart fail-
ure (HR, 1.59; 95% CI, 0.92-2.73), and cerebrovascular events
(HR, 1.47; 95%CI, 1.15-1.87) in theage interval of40 to70years
compared with women with normotensive pregnancies
(Table 2). These HRswere consistently higher amongwomen
with ahistory of preeclampsia than amongwomenwith ahis-
tory of gestational hypertension only. At older than 70 years,
womenwith a history ofHDPhad lower hazard rates formost
subtypes of CVD compared with women with normotensive
pregnancies, but limited observations and events for this age
interval prevented precise estimates.
Competing risk models gave virtually identical HRs to
those estimated in the main analysis (results not shown),
suggesting censoring was uninformative. Sensitivity analyses
Table 1. Descriptive Characteristics of the Study Population
Maternal
Characteristic
Pregnancy Status, No. (%)a
Always Normotensive
(n = 21 766)
Ever Hypertensive
Disorder (n = 2119)
Gestational
Hypertension Only
(n = 728)
Ever
Preeclampsia
(n = 1391)
Birth y, median (IQR) 1954 (1946-1962) 1955 (1948-1963) 1953 (1946-1960) 1957
(1949-1964)
Age at first birth, y 24 (21-27) 23 (21-27) 23 (21-27) 24 (21-27)
Parity at younger
than 40 y
1 4907 (23) 323 (15) 113 (16) 210 (15)
2 9149 (42) 887 (42) 300 (41) 587 (42)
≥3 7710 (35) 909 (43) 315 (43) 594 (43)
First birth recorded
in the MBRN
No 4190 (19) 214 (10) 113 (16) 101 (7)
Yes 17576 (81) 1905 (90) 615 (84) 1290 (93)
Family history of
coronary heart
disease
No 13991 (64) 1328 (63) 456 (63) 872 (63)
Yes 7775 (36) 791 (37) 272 (37) 519 (37)
Ever smoked daily
No 8161 (37) 1041 (49) 336 (46) 705 (51)
Yes 13605 (63) 1078 (51) 392 (54) 686 (49)
Education
Lower secondary 5562 (26) 517 (24) 211 (29) 306 (22)
Upper secondary 9412 (43) 949 (45) 317 (44) 632 (45)
Tertiary 6792 (31) 653 (31) 200 (27) 453 (33)
Age at measurement
of cardiovascular risk
factors, y, median
(IQR)
50 (41-59) 48 (40-56) 51 (41-58) 46 (39-55)
Abbreviations: IQR, interquartile
range; MBRN, Medical Birth Registry
of Norway.
a Pregnancy status designates
presence of hypertensive disorder,
preeclampsia, or gestational
hypertension in births at younger
than 40 years.
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restricted to women who had their first birth recorded in the
MBRN also yielded similar, but slightly lower and more
imprecise HRs (eTables 3-6 in the Supplement). Sensitivity
analyses restricted to validated diagnoses (eTables 7 and 8 in
the Supplement) gave almost identical results to the main
analyses.
Contribution of Cardiovascular Risk Factors
to CVD Risk inWomenWith History of HDP
All associations between HDP and CVD described in this sec-
tion areHRs based on theCoxproportional hazardsmodel in-
cluding person-time from 40 to 70 years. Because the asso-
ciationsbetweenHDPandCVDwere reversed forwomenolder
Table 2. Hazard Ratios for Cardiovascular Events inWomenWith Hypertensive Disorder of Pregnancy
Event
No. of Events/
No. of Women Person-Years Model 1, HR (95% CI)a P Value Model 2, HR (95% CI)b P Value
Any CVD event
Age (40-70 y)
Always normotensive 1155/21 752 37 4372 1 [Reference] NA 1 [Reference] NA
Ever hypertensive disorder 145/2117 34 802 1.45 (1.22-1.72) <.001 1.57 (1.32-1.86) <.001
Ever preeclampsia 91/1389 21 714 1.52 (1.23-1.88) <.001 1.66 (1.34-2.06) <.001
Ever gestational hypertension 54/728 13 088 1.34 (1.02-1.76) .04 1.43 (1.09-1.88) .01
Age (70-88 y)
Always normotensive 375/3499 91 989 1 [Reference] NA 1 [Reference] NA
Ever hypertensive disorder 13/225 5957 0.59 (0.34-1.02) .06 0.59 (0.34-1.04) .07
Ever preeclampsia 8/129 3406 0.70 (0.35-1.42) .33 0.71 (0.35-1.43) .33
Ever gestational hypertension 5/96 2551 0.46 (0.19-1.12) .09 0.47 (0.20-1.15) .10
Myocardial infarction
Age (40-70 y)
Always normotensive 383/21 752 380 698 1 [Reference] NA 1 [Reference] NA
Ever hypertensive disorder 54/2117 35 533 1.64 (1.23-2.18) .001 1.86 (1.40-2.48) <.001
Ever preeclampsia 35/1389 22 119 1.78 (1.26-2.52) .001 2.08 (1.46-2.95) <.001
Ever gestational hypertension 19/728 13 413 1.43 (0.90-2.26) .13 1.56 (0.99-2.48) .06
Age (70-88 y)
Always normotensive 112/3499 92 782 1 [Reference] NA 1 [Reference] NA
Ever hypertensive disorder 4/225 5997 0.58 (0.21-1.57) .29 0.66 (0.24-1.79) .41
Ever preeclampsia 2/129 3437 0.57 (0.14-2.30) .43 0.64 (0.16-2.61) .53
Ever gestational hypertension 2/96 2560 0.59 (0.15-2.40) .46 0.67 (0.17-2.73) .58
Heart failure
Age (40-70 y)
Always normotensive 140/21 752 383 087 1 [Reference] NA 1 [Reference] NA
Ever hypertensive disorder 16/2117 35 850 1.47 (0.86-2.52) .16 1.59 (0.92-2.73) .10
Ever preeclampsia 13/1389 22 316 1.83 (0.99-3.40) .06 2.00 (1.07-3.73) .03
Ever gestational hypertension 6/728 13 534 0.96 (0.35-2.60) .94 1.01 (0.37-2.75) .97
Age (70-88 y)
Always normotensive 73/3499 92 975 1 [Reference] NA 1 [Reference] NA
Ever hypertensive disorder 4/225 5994 0.87 (0.35-2.14) .76 0.98 (0.39-2.44) .97
Ever preeclampsia 2/129 3441 0.97 (0.31-3.06) .96 1.07 (0.33-3.41) .91
Ever gestational hypertension 2/96 2553 0.76 (0.19-3.07) .70 0.87 (0.21-3.57) .85
Cerebrovascular disease
Age (40-70 y)
Always normotensive 617/21 752 378 902 1 [Reference] NA 1 [Reference] NA
Ever hypertensive disorder 75/2117 35 324 1.40 (1.10-1.78) .006 1.47 (1.15-1.87) .002
Ever preeclampsia 46/1389 22 035 1.46 (1.08-1.97) .01 1.52 (1.13-2.06) .006
Ever gestational hypertension 29/728 13 289 1.32 (0.90-1.93) .15 1.38 (0.95-2.02) .10
Age (70-88 y)
Always normotensive 178/3499 92581 1 [Reference] NA 1 [Reference] NA
Ever hypertensive disorder 8/225 5967 0.78 (0.40-1.52) .47 0.75 (0.38-1.48) .41
Ever preeclampsia 6/129 3411 0.98 (0.43-2.20) .95 0.93 (0.41-2.10) .86
Ever gestational hypertension 2/96 2555 0.56 (0.18-1.74) .31 0.55 (0.18-1.73) .31
Abbreviations: CVD, cardiovascular disease; HR, hazard ratio; NA, not
applicable.
a Adjusted for age.
bAdjusted for age, highest obtained educational level, ever smoked daily, parity
at younger than 40 years, maternal birth year, and family history of coronary
heart disease.
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than 70 years, nomediation analyseswere performed for this
age interval. The associations betweenHDPandCVDdiffered
slightly according towhich cardiovascular risk factorwas ana-
lyzed owing to variations in study population but fell within
a fairlynarrowrangeof 1.53 to 1.58 (Table 3).Wecalculated the
percentage excess risk associated with each risk factor by di-
viding the β coefficient for the part of the association be-
tween HDP and CVD that was associated with the cardiovas-
cular risk factor(s)with theβcoefficient for the total association
betweenHDP and CVD. The proportion of the association be-
tween HDP and CVD that was associated with BMI was 41%,
corresponding to anHRof 1.19 (95%CI, 1.07-1.33). Systolic and
diastolic blood pressurewas associatedwith 60% and 73% of
the association betweenHDP andCVD, corresponding toHRs
of 1.30 (95%CI, 1.16-1.47) and 1.38 (95%CI, 1.23-1.55), respec-
tively. Combining BMI with systolic and diastolic pressure in
2 separatemediation analyses showed that BMI togetherwith
systolic anddiastolic bloodpressurewas associatedwith67%
and 79%of the excess cardiovascular risk inwomenwith his-
tory of HDP, respectively (Table 3).
Wehadfewerobservationsofnonfastingglucose levelsand
non-HDL cholesterol levels because these risk factors were
not routinely assessed in HUNT1. Glucose was associated
with 25% and non-HDL cholesterol was associated with 24%,
corresponding to HRs of 1.12 (95% CI, 1.02-1.23) and 1.11 (95%
CI, 1.02-1.21), respectively (Table 3). All risk factors combined
(BMI, blood pressure, glucose, and non-HDL cholesterol) did
not have a greater association with excess cardiovascular risk
than the combination of BMI and blood pressure (results not
shown).
Separate mediation analyses for history of preeclampsia
and gestational hypertension suggested that blood pressure
had a greater association with cardiovascular risk in women
with gestational hypertension, where it was associated with
all excess risk. In women with preeclampsia, the mediators
were maximally associated with 79% of the excess risk
(eTables 9 and 10 in the Supplement). Analyses of CVD sub-
types indicated that bloodpressurewas associatedwithmost
of the excess risk of heart failure and cerebrovascular events
inwomenwith a history of HDP, but only up to 41% of the ex-
cess risk ofmyocardial infarction (eTables 11-13 in the Supple-
ment). Excluding the 484womenwhohad their cardiovascu-
lar risk factors measured before first pregnancy did not
substantially alter our results (results not shown). Among the
approximately 18000 women who had their cardiovascular
risk factors measured at older than 40 years, the proportions
of excess CVD risk in women with a history of HDP that was
associated with the cardiovascular risk factors was moder-
ately reducedcomparedwith theoverall studypopulationand
maximally were associated with 47% of the excess risk
(eTable 14 in the Supplement).
Discussion
In this population-based cohort study, womenwith a history
of HDP had approximately 60% higher risk of CVD until age
70years comparedwithwomenwithnormotensive pregnan-
cies. About 79% of the excess CVD risk was associated with
blood pressure and BMI, indicating that these risk factors are
important targets forCVDprevention in thesewomen.Therela-
tive risk of CVD was slightly larger for women who experi-
encedpreeclampsia comparedwith gestational hypertension
andhigher formyocardial infarction than for heart failure and
cerebrovascular events. Theproportionof excess CVD risk as-
sociated with blood pressure and BMI was moderately lower
amongwomenwhohad their cardiovascular risk factorsmea-
sured at older than 40 years, suggesting that earliermeasure-
Table 3. Association Between Hypertensive Pregnancy Disorders and Cardiovascular Disease and BMI, Blood Pressure,
and SerumGlucose and Lipid Levels inWomen Aged 40 to 70 Years
Cardiovascular
Risk Factors
Women,
No.
Total Association
Between HDP and CVD
Part of Association Between HDP
and CVD That Is Not Associated
With the Examined Cardiovascular
Risk Factors
Part of Association Between
HDP and CVD That Is Associated
With the Examined Cardiovascular
Risk Factors
Proportion of Excess
Cardiovascular Risk
in Women Who Had
HDP That Is
Associated With
Cardiovascular Risk
Factor(s), %bHR (95% CI)a P Value HR (95% CI)a P Value HR (95% CI)a P Value
BMI 23 508 1.54 (1.29-1.83) <.001 1.29 (1.06-1.56) .01 1.19 (1.07-1.33) .001 41
Systolic blood
pressure
23 500 1.55 (1.29-1.86) <.001 1.19 (0.97-1.47) .10 1.30 (1.16-1.47) <.001 60
Diastolic blood
pressure
23 501 1.55 (1.30-1.85) <.001 1.13 (0.92-1.38) .25 1.38 (1.23-1.55) <.001 73
Glucose 21 881 1.58 (1.30-1.92) <.001 1.40 (1.15-1.72) .001 1.12 (1.02-1.23) .01 25
Non-HDL
cholesterol
21 517 1.53 (1.26-1.88) <.001 1.38 (1.12-1.69) .002 1.11 (1.02-1.21) .02 24
BMI and systolic
blood pressure
23 453 1.53 (1.27-1.84) <.001 1.15 (0.91-1.44) .23 1.33 (1.16-1.53) <.001 67
BMI and
diastolic blood
pressure
23 454 1.53 (1.28-1.83) <.001 1.09 (0.88-1.36) .43 1.40 (1.22-1.61) <.001 79
Abbreviations: BMI, bodymass index (calculated as weight in kilograms divided
by height in meters squared); CVD, cardiovascular disease; HDL, high-density
lipoprotein; HDP, hypertensive disorders of pregnancy.
a Estimates are adjusted for age, highest obtained educational level, ever
smoked daily, parity at younger than age 40 years, maternal birth year, and
family history of coronary heart disease.
bWe calculated the percentage excess risk associated with each risk factor by
dividing the β coefficient for the part of the association between HDP and CVD
that was associated with the cardiovascular risk factor(s) with the β coefficient
for the total association between HDP and CVD.
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mentsof cardiovascular risk factors ismore informative about
later CVD risk in women with history of HDP.
To our knowledge, no previous mediation analysis has
combined measurements of cardiovascular risk factors with
validated cardiovascular events to examine this topic, but our
results are supported by an abstract from the Nurses’ Health
Study II18 showing that self-reported cardiovascular risk fac-
tors, in particular chronic hypertension,were associatedwith
most of the excess CVD risk associated with HDP. Informa-
tion on which modifiable factors explain the excess CVD risk
in women with history of HDP is a key requisite to inform
prevention of CVD in these women. Previous large Nordic
studies19-24 have used data from national health registries to
quantify the association between HDP and future CVD. How-
ever, some of them included fatal events only,21,22 few stud-
ies examined the risk of heart failure and cerebrovascular
events, andnonehadmeasurementsof cardiovascular risk fac-
tors to performmediation analyses.
Our estimates of the associations between HDP and fu-
ture CVD are generally consistent with those of previous
studies,1-5,19 but our point estimates are on the lower end of
the spectrum.1-5,19,20 Most studies and meta-analyses report
a doubling in CVD risk for preeclampsia,1-4 but previous co-
hort studies19-24 in comparable study populations reported
associations that are relatively similar to our results. For ex-
ample, in a nationwideNorwegian study,20 preeclampsiawas
associated with an HR of 1.6 for CVD mortality and an HR of
2.1 formajorcoronaryevents,andgestationalhypertensionwas
associatedwithanHRof1.8 forCVD.19 InaSwedishstudypopu-
lation,womenwithgestational hypertensionandmild and se-
vere preeclampsia had relative risks of ischemic heart disease
of 1.6, 1.9, and 2.8, respectively.23 Similar estimates for vari-
ous CVD end points were observed in a Danish population.24
Fewer studies have examined the associations of HDP with
heart failure and cerebrovascular events, but a history of pre-
eclampsiawasassociatedwitha3.6-fold increased riskofheart
failure in a meta-analysis.2 Meta-analyses of the association
between a history of preeclampsia and cerebrovascular dis-
easehave reportedanHRof2.04andanodds ratioof 1.8.1Most
previousstudies followedupthewomenfromthe timeofpreg-
nancy, whereas we could not follow up women between the
start of the MBRN in 1967 and the introduction of electronic
hospital records in 1987. In this younger age group, the rela-
tive risk ofCVD inwomenwith ahistoryofHDPmaybehigher
(even if theabsolute risk is low),whichcouldexplain the lower
HRs observed in our study. Although we did not have statis-
tical power to make conclusive inferences about the associa-
tionbetweenHDPandCVDamongwomenolder than70years,
the apparent reversal of the HRs at old age is similar to what
has been observed between cardiovascular risk factors and
mortality in elderly populations25 andmay be a result of sur-
vivor bias.
Strengths and Limitations
Ourstudywas,withamedian follow-upof 18years, longer than
the follow-up reported in the other Nordic studies.19-23 We
started follow-up timeafterwomen largely finished reproduc-
ing at age 40 years to avoid introducing immortal time bias.26
Compared with most other studies relying on registry or ad-
ministrative event data only, our study had the advantage of
havingclinicallymeasured informationaboutconventionalcar-
diovascular risk factors and having validated 93% of the car-
diovascularoutcomes, thusensuringhighspecificityof theout-
come variables. However, we acknowledge that the available
tests for CVD have changed throughout our study period and
that this couldpotentiallyhaveaffectedourestimates.Wealso
acknowledge thatwemayhavemissednonfatal eventswhere
the patientwas not admitted to hospital, but owing to the ex-
cellent public access to health care inNorway throughout the
studyperiod, thisnumber isexpectedlyvery low.Also,anymis-
classificationwould expectedly not dependonHDPor the ex-
amined mediators, and we consider it unlikely that this may
have substantially influencedour results.Additionally,wehad
access toabroadrangeof relevantconfounders fromtheHUNT
study, enabling analyses of the associationof these cardiovas-
cular risk factorswith theexcess cardiovascular risk inwomen
with history of HDP. For this purpose, we used a novel ap-
proach tomediation analysis15 that allowedus to perform for-
mal mediation analyses for single and joint effects of several
cardiovascular risk factors on the association between HDP
and CVD in a survival setting while adjusting for multiple
confounders. Our mediation results are probably generaliz-
able tootherpopulationswhere, as inNorway, access tohealth
care is free and clinical follow-up is generally good. However,
the association of these cardiovascular risk factors with later
CVD risk may be lower in our and similar populations com-
pared with populations where no or little medical treatment
of cardiovascular risk factors takes place, ie, in populations
where health care access is more limited.
Conclusions
Our study has shown that women with history of HDP have
an increased riskofCVDthat is toa largeextentassociatedwith
increased levels of conventional, modifiable cardiovascular
risk factors. Blood pressure plays a substantial role in driving
the excess cardiovascular risk in women who experienced
preeclampsia and an even larger role in women who experi-
enced gestational hypertension. The association of conven-
tional risk factors, in particular blood pressure and BMI, with
the development of CVD inwomenwith historyHDP indicate
that preventive efforts aimed at decreasing the levels of these
risk factors could reduce cardiovascular risk in women with
history of HDP.
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